Taiwania Capital

FIGUR8 is formed by a group of engineers, researchers and designers with expertise in wearable computing, digital health and sports science. We share the same passion in creating the most intuitive and effective way to understanding human movement and to bring what’s only available to the elite few today to the hands of the everyday user.

Elixiron Immunotherapeutics is a company developing therapeutics for cancer, neurological diseases, and inflammatory disorders.

Oculii is an advanced radar sensor developer specializing in 4D radar design and fusion. 4D sensors have traditionally been the domain of high power, expensive military grade radar or laser systems. Backed by top-tier Silicon Valley angel investors and VCs - they've turned this paradigm on its head, leveraging advanced sensor fusion techniques to manufacture smarter, high precision sensors and systems. Their technology allows us to extract unprecedented accuracy, range, and 4D positioning information from commodity off the shelf low-cost radar elements, bringing high resolution radar imaging to the next frontier.

Tripresso is an online travel agent (OTA) mainly focus on package tour products. It started off by offering an online marketplace for package tour suppliers such as Lions Travel and Richmond, and it also builds a simple search engine for end customers to find suitable products. After that, it expands the product scope to hotels, flight tickets, and customized travel plans for outbound travel. In 2018, Tripresso launched a proprietary software-as-a-service (SaaS) system, TripSaaS, which allows brick-and-mortar travel agencies to manage websites, list products, and manage orders and customer relationships to enhance operational efficiency. The company was founded in 2013 in Taipei, Taiwan.

Enable objects to wirelessly communicate valuable information to its users

Founded in 2009, Kdan Mobile, a global SaaS (Software as a Service) company, has focused on building mobile software applications and online services that allow users to better leverage their productivity and creativity. With offices in Taiwan, China, the U.S., and Japan, Kdan Mobile’s work has been backed by more than 200 million downloads worldwide. Our solutions empower the world to create, distribute, and conjoin projects via the use of mainstream digital devices.

Landing.AI (Us) Corp. develops artificial intelligence transformation programs for manufacturing industry. The company develops solutions around visual inspection, controlling and automating, calibration and tuning, and automated issue identification for large manufacturer partners. It serves manufacturing, retail / ecommerce, automotive, agriculture, telecommunications, and pharmaceutical industries. The company was incorporated in 2017 and is based in Palo Alto, California.

WindGap Medical is a biotech company that manufactures medical devices used to treat patients with severe allergies. The company develops auto-injectors that are filled with heat-stable epinephrine that enable physicians to inject it into a patient suffering from anaphylaxis due to an acute allergy attack. The company was established in 2011 and is headquartered in Somerville, Massachusetts.

HemaQuest Pharmaceuticals, Inc. provides pharmaceutical products. The Company develops small molecule therapeutics to treat serious and life threatening hematologic disorders, including anemia, beta thalassemia, sickle cell anemia, and neutropenia. HemaQuest Pharmaceuticals operates in the United States.

Oculii is an advanced radar sensor developer specializing in 4D radar design and fusion. 4D sensors have traditionally been the domain of high power, expensive military grade radar or laser systems. Backed by top-tier Silicon Valley angel investors and VCs - they've turned this paradigm on its head, leveraging advanced sensor fusion techniques to manufacture smarter, high precision sensors and systems. Their technology allows us to extract unprecedented accuracy, range, and 4D positioning information from commodity off the shelf low-cost radar elements, bringing high resolution radar imaging to the next frontier.

Nanolive SA designs and develops devices that scan living cells. The company offers 3D Cell Explorer that allows users to explore the inside of a living cell in 3D without the need for labeling or other invasive methods. Its device scans cell division, cell organelles and cell morphology, cell differentiation, cell-cell interaction, intracellular trafficking, cellular remodeling processes, cell death (apoptosis or necrosis), drug monitoring, and in vitro fertilization. Nanolive SA was incorporated in 2013 and is headquartered in Ecublens, Switzerland.

Pavilion Data Systems Inc. designs and develops NVMe-over-Fabric storage platform that ingests, processes, stores, and serves massively-parallel applications. The company also provides OPENCHOICE, a model that defies conventional thinking about how storage is procured and deployed; and Pavilion Data OS that enable Internet and SaaS companies, cloud service providers, and enterprises to deliver business-critical applications. It offers its solutions for financial services, government solutions, hyper scale and cloud, media and entertainment, and research facilities. Pavilion Data Systems Inc. was incorporated in 2011 and is based in San Jose, California. It has additional offices in Schiphol, the Netherlands; and Pune, India.

Arris Composites is an industrial engineering company that specializes in the fields of machinery manufacturing, automotive, and aerospace. It provides next-Gen composites for mass-market applications including aerospace, automotive, and consumer products. The company was founded in 2017 and headquartered in Berkeley, California.

Verana Networks develops an innovative 5G Radio Access Network solution for service providers that have licensed millimeter wave (mmWave) spectrum. The company focuses on enabling 5G in mmWave spectrum because that is where the largest amount of new spectrum is. For 5G to succeed, it must deliver a 10X-50X increase in speed and capacity. Blazing fast speed and an increase in capacity enable new applications, these new applications create incremental revenue, and incremental revenue is essential to support the business case for 5G.

Appaegis simplifies enterprise data access while enforcing strong zero-trust security for remote access. Its patent-pending solution protects data access and gives administrators full control over how enterprise data is used. The company was founded by security veterans with successful security track records.

Make CMS Simple | Agile Content Management System for faster delivery and stability with any data sources.

Metanoia Communications (”Metanoia”) was established in Hsinchu Science Park, Taiwan in 2004. Metanoia develops semiconductor and software solutions to the Wireline broadband market and the in-home networking market, providing very high-speed PHY chipsets to the broadband manufacturers. Metanoia combines “state of the art” system architecture and algorithm expertise with extensive integrated circuit design capabilites to deliver a broad range of fixed line communication products for access and In-home applications. Their portfolio includes products for the xDSL markets (more specifically for the VDSL2 and the upcoming G.fast markets), and the G.hn market.

Fractyl Laboratories Inc. develops a minimally invasive procedural therapy for metabolic diseases. It offers Revita DMR, a duodenal mucosal resurfacing therapy to rejuvenate the lining of the duodenum. Its Revita DMR procedure uses hydrothermal ablation to safely remove the excessive layer of the duodenal mucosa that develops due to high fat and sugar diets. Fractyl Laboratories Inc. was formerly known as MedCatalyst, Inc. and changed its name to Fractyl Laboratories Inc. in January 2012. The company was incorporated in 2010 and is based in Lexington, Massachusetts.

Enable objects to wirelessly communicate valuable information to its users

Ambiq Micro is an early-stage fabless semiconductor company that is developing ultra-low-power mixed-signal solutions for a new generation of wireless electronics. Ambiq Micro was founded in 2010 on the simple yet powerful notion that extremely low power semiconductors are the key to the future of electronics. Through the use of their pioneering ultra-low-power technology, they help innovative companies around the world develop differentiated solutions that reduce or eliminate the need for batteries, lower overall system power, and maximize industrial design flexibility.

Ambiq Micro is an early-stage fabless semiconductor company that is developing ultra-low-power mixed-signal solutions for a new generation of wireless electronics. Ambiq Micro was founded in 2010 on the simple yet powerful notion that extremely low power semiconductors are the key to the future of electronics. Through the use of their pioneering ultra-low-power technology, they help innovative companies around the world develop differentiated solutions that reduce or eliminate the need for batteries, lower overall system power, and maximize industrial design flexibility.

AEye is an artificial perception pioneer and creator of iDAR, a perception system that acts as the eyes and visual cortex of autonomous vehicles. Since the demonstration of its solid-state LiDAR scanner in 2013, AEye has pioneered breakthroughs in intelligent sensing. The company is based in the San Francisco Bay Area and backed by world-renowned investors including Kleiner Perkins Caufield and Byers, Taiwania Capital, Hella Ventures, LG Electronics, Subaru-SBI, Aisin, Intel Capital, Airbus Ventures, and others.

Ambiq Micro is an early-stage fabless semiconductor company that is developing ultra-low-power mixed-signal solutions for a new generation of wireless electronics. Ambiq Micro was founded in 2010 on the simple yet powerful notion that extremely low power semiconductors are the key to the future of electronics. Through the use of their pioneering ultra-low-power technology, they help innovative companies around the world develop differentiated solutions that reduce or eliminate the need for batteries, lower overall system power, and maximize industrial design flexibility.

Suono Bio is developing platform technology designed to enable ultra-rapid delivery of therapeutics, including proteins and nucleic acids, to the gastrointestinal (GI) tract. Preclinical studies have demonstrated the capacity to deliver small molecules, proteins, vaccines, and nucleic acids locally and systemically, validating further development of the system.

Avesha is a technology platform that enables application workloads to disaggregate across cloud, multi-cloud, and edge locations. Enterprises can improve business outcomes by enabling more automation, real-time use cases, and high performance/low latency applications by distributing data and application logic closer to the end-users. The Avesha SNAP (Smart Network Application Platform) creates a virtual overlay on any network underlay. The company was founded in 2019 and is headquartered in Burlington, Massachusetts.

Landing.AI (Us) Corp. develops artificial intelligence transformation programs for manufacturing industry. The company develops solutions around visual inspection, controlling and automating, calibration and tuning, and automated issue identification for large manufacturer partners. It serves manufacturing, retail / ecommerce, automotive, agriculture, telecommunications, and pharmaceutical industries. The company was incorporated in 2017 and is based in Palo Alto, California.

Light Field Lab, Inc. develops holographic capture display technology systems. It offers integrated processing and imaging solutions that allow immersive visuals to be delivered over commercial network speeds. The company also develops a universal application programming interface to streamline the process of bringing existing content to a light field display with holographic media. Light Field Lab, Inc. was incorporated in 2016 and is based in Morgan Hill, California.

FIGUR8 is formed by a group of engineers, researchers and designers with expertise in wearable computing, digital health and sports science. We share the same passion in creating the most intuitive and effective way to understanding human movement and to bring what’s only available to the elite few today to the hands of the everyday user.

Light Field Lab, Inc. develops holographic capture display technology systems. It offers integrated processing and imaging solutions that allow immersive visuals to be delivered over commercial network speeds. The company also develops a universal application programming interface to streamline the process of bringing existing content to a light field display with holographic media. Light Field Lab, Inc. was incorporated in 2016 and is based in Morgan Hill, California.

AEye is an artificial perception pioneer and creator of iDAR, a perception system that acts as the eyes and visual cortex of autonomous vehicles. Since the demonstration of its solid-state LiDAR scanner in 2013, AEye has pioneered breakthroughs in intelligent sensing. The company is based in the San Francisco Bay Area and backed by world-renowned investors including Kleiner Perkins Caufield and Byers, Taiwania Capital, Hella Ventures, LG Electronics, Subaru-SBI, Aisin, Intel Capital, Airbus Ventures, and others.

Avesha is a technology platform that enables application workloads to disaggregate across cloud, multi-cloud, and edge locations. Enterprises can improve business outcomes by enabling more automation, real-time use cases, and high performance/low latency applications by distributing data and application logic closer to the end-users. The Avesha SNAP (Smart Network Application Platform) creates a virtual overlay on any network underlay. The company was founded in 2019 and is headquartered in Burlington, Massachusetts.

Fractyl Laboratories Inc. develops a minimally invasive procedural therapy for metabolic diseases. It offers Revita DMR, a duodenal mucosal resurfacing therapy to rejuvenate the lining of the duodenum. Its Revita DMR procedure uses hydrothermal ablation to safely remove the excessive layer of the duodenal mucosa that develops due to high fat and sugar diets. Fractyl Laboratories Inc. was formerly known as MedCatalyst, Inc. and changed its name to Fractyl Laboratories Inc. in January 2012. The company was incorporated in 2010 and is based in Lexington, Massachusetts.

Light Field Lab, Inc. develops holographic capture display technology systems. It offers integrated processing and imaging solutions that allow immersive visuals to be delivered over commercial network speeds. The company also develops a universal application programming interface to streamline the process of bringing existing content to a light field display with holographic media. Light Field Lab, Inc. was incorporated in 2016 and is based in Morgan Hill, California.

HemaQuest Pharmaceuticals, Inc. provides pharmaceutical products. The Company develops small molecule therapeutics to treat serious and life threatening hematologic disorders, including anemia, beta thalassemia, sickle cell anemia, and neutropenia. HemaQuest Pharmaceuticals operates in the United States.

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the transitory activation of these progenitor cells, Frequency enables disease modification without the complexity of genetic engineering. It was founded in 2015 and headquartered in Woburn, Massachusetts.

AEye is an artificial perception pioneer and creator of iDAR, a perception system that acts as the eyes and visual cortex of autonomous vehicles. Since the demonstration of its solid-state LiDAR scanner in 2013, AEye has pioneered breakthroughs in intelligent sensing. The company is based in the San Francisco Bay Area and backed by world-renowned investors including Kleiner Perkins Caufield and Byers, Taiwania Capital, Hella Ventures, LG Electronics, Subaru-SBI, Aisin, Intel Capital, Airbus Ventures, and others.

C4 is building on the knowledge with synthetic chemical compounds which it calls Degronimids. These compounds can be engineered and linked together to bind with many molecular targets that today’s drugs can’t bind with, Cohen said. The key insight, he said, is that the scientific founders have discovered a way to bind with select disease-causing proteins, and flag them as cellular trash, so that the ordinary proteasome garbage disposal system can get rid of them. Selecting the precise disease-related proteins to send to the trash is obviously critical, because any drug like this could cause serious side effects if it sent healthy proteins involved in normal cell processes to the trash. C4 Therapeutics is developing a new class of targeted protein degradation (TPD) therapeutics for the treatment of a broad range of diseases. Our Degronimid™ platform incorporates highly selective small molecule binders to target disease-causing proteins and facilitate their rapid destruction and clearance from the cell through the natural ubiquitin/proteasome system (UPS). Because of this distinctive mechanism, Degronimids are capable of hitting many more targets, including those previously thought to be undruggable, while reducing the potential for drug resistance. The broad applicability of Degronimids, and our chemical biology platform designed for accelerated validation, have the potential to make an unprecedented impact across many diseases through multiple industry collaborations as well as proprietary programs. The Company has received an exclusive worldwide license to the Degronimid platform and related IP from Dana-Farber.

DSP Concepts is unleashing the power of sound Sound gives us context. Next generation technology depends on intelligent audio input to help drive decisions. Noisy, windy envinroments prevent intelligent recognition of audio context. Each product demands different acoustic tuning. Our world class customers depend on us to bring them differentiation and best in class processing solutions tuneable to their form factor. Our solutions are built around Audio Weaver, the only processor agnostic platform for efficient embedded audio processing. Along with our proprietary algorithms, we collaborate with 3rd party algorithm providers to bring a full solution for your products. Reduce audio development time by 90% and bring amazing products to market faster. Clientele include the most prestigious names in the industry: Sirius/XM, Tesla, Porsche, GoPro, Daimler, Samsung, and Facebook.

Regenacy Pharmaceuticals is developing a novel, disease-modifying approach to treating peripheral neuropathies that goes beyond pain and symptom management to restore peripheral nerve function. Its compound ricolinostat (ACY-1215) is an oral, selective inhibitor of the microtubule modifying enzyme HDAC6 with the first-in-class potential, currently positioned to enter Phase 2 clinical trials. Its investigation of ricolinostat for diabetic, chemotherapy-induced, and inherited peripheral neuropathies is based on compelling proof-of-concept preclinical studies demonstrating restoration of normal nerve function.

Pavilion Data Systems Inc. designs and develops NVMe-over-Fabric storage platform that ingests, processes, stores, and serves massively-parallel applications. The company also provides OPENCHOICE, a model that defies conventional thinking about how storage is procured and deployed; and Pavilion Data OS that enable Internet and SaaS companies, cloud service providers, and enterprises to deliver business-critical applications. It offers its solutions for financial services, government solutions, hyper scale and cloud, media and entertainment, and research facilities. Pavilion Data Systems Inc. was incorporated in 2011 and is based in San Jose, California. It has additional offices in Schiphol, the Netherlands; and Pune, India.

Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the transitory activation of these progenitor cells, Frequency enables disease modification without the complexity of genetic engineering. It was founded in 2015 and headquartered in Woburn, Massachusetts.